154 related articles for article (PubMed ID: 8601561)
1. Growth patterns and cell kinetics of human osteosarcoma xenografts in serial passages in nude mice analyzed by in vivo labelling with iododeoxyuridine.
Broström LA; Crnalic S; Löfvenberg R; Boquist L; Stenling R
J Cancer Res Clin Oncol; 1996; 122(3):141-46. PubMed ID: 8601561
[TBL] [Abstract][Full Text] [Related]
2. Structure, growth and cell proliferation of human osteosarcoma and malignant fibrous histiocytoma xenografts in serial transplantation in nude mice.
Broström LA; Crnalic S; Löfvenberg R; Stenling R; Boquist L
APMIS; 1996 Nov; 104(11):775-83. PubMed ID: 8982240
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma and interferon. Studies of human xenografts in the nude mouse.
Brosjö O
Acta Orthop Scand Suppl; 1989; 229():1-36. PubMed ID: 2494840
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
[TBL] [Abstract][Full Text] [Related]
6. Growth and ploidy of human osteosarcoma xenografts in serial passage in nude mice.
Bauer HC; Brosjö O; Broström LA; Nilsson OS; Reinholt FP; Tribukait B
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):821-30. PubMed ID: 3464431
[TBL] [Abstract][Full Text] [Related]
7. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].
Gorisse MC; Desoize B; Carpentier Y; Nguyen TD
Bull Cancer; 1996 Oct; 83(10):825-34. PubMed ID: 8952632
[TBL] [Abstract][Full Text] [Related]
8. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Haustermans K; Fowler JF
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
[TBL] [Abstract][Full Text] [Related]
10. Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues.
Pollack A; White RA; Cao S; Meistrich ML; Terry NH
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1131-9. PubMed ID: 8262838
[TBL] [Abstract][Full Text] [Related]
11. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
12. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
[TBL] [Abstract][Full Text] [Related]
14. Measurement of potential doubling time for human tumor xenografts using the cytokinesis-block method.
Hlatky L; Olesiak M; Hahnfeldt P
Cancer Res; 1996 Apr; 56(7):1660-3. PubMed ID: 8603417
[TBL] [Abstract][Full Text] [Related]
15. Cell kinetic analysis of non-Hodgkin's lymphomas using in vivo iododeoxyuridine incorporation and flow cytometry.
Erlanson M; Lindh J; Zackrisson B; Landberg G; Roos G
Hematol Oncol; 1995; 13(4):207-17. PubMed ID: 7557897
[TBL] [Abstract][Full Text] [Related]
16. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
van Oostrum IE; Rozemuller E; Knol RF; Erkens-Schulze S; Rutgers DH
Cell Tissue Kinet; 1990 Nov; 23(6):523-44. PubMed ID: 2276171
[TBL] [Abstract][Full Text] [Related]
19. Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice.
Baisch H; Otto U; Fack H
Eur Urol; 1998 Dec; 34(6):505-11. PubMed ID: 9831793
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human osteosarcoma HuO9 cells by methylglyoxal bis(cyclopentylamidinohydrazone) in vitro and in vivo.
Satoh N; Hibasami H; Mori K; Kaneko H; Wakabayashi H; Hirata K; Sonoda J; Nakashima K; Uchida A
Oncol Rep; 1999; 6(3):627-30. PubMed ID: 10203604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
